LETTER TO MR. O'GRADY FROM (DELETED) RE YOUR FILE NO. L4730, MRS. VAL ORLIKOW

Document Type: 
Collection: 
Document Number (FOIA) /ESDN (CREST): 
00295518
Release Decision: 
RIPPUB
Original Classification: 
U
Document Page Count: 
2
Document Creation Date: 
January 23, 2025
Document Release Date: 
March 3, 2000
Sequence Number: 
Case Number: 
Publication Date: 
February 15, 1979
File: 
Body: 
Ccntral Intclligcncc Agcncy WashingtoriMGMM February 5, 1979 M. James O'Grady, Esq. Soloway, Wright, Houston, Greenberg O'Grady, Morin Barristers, Solicitors and Notaries 170 Metcalfe Street Ottawa, Ontario K22 1P3 Dear Mr. O'Grady: Re: Your File No. L4730, Mrs. Val Orlikow As I advised you in my 12 September 1978 letter, the United States Department of Justice determined this Agency may have a legal obligation to identify, locate and notify any unwitting subjects of MKULTRA drug-testing activities where it can be reasonably determined their health may continue to be adversely affected by their prior involvement in that program. Your letter of 6 February 1978 suggesting a compensa- tory payment to Mrs. Orlikow as an alleged "unsuspecting Participant in CIA-sponsored experiments" indicated that Mrs. Orlikow "was a patient at the Allan Memorial Institute in Montreal under the care of Dr. D. Ewen Cameron on two occasions; the first between November 1956 and March 1957, and the second between July 1963 and May 1964." The records available to the Agency concerning CIA support of research at McGill indicate that this work had been underway since 1953 without CIA support. An unsolic- ited proposal for a grant was received from the Allan Memorial Institute in January 1957 and CIA funding did not actually begin until April 1957. Agency records indicate CIA funding of this research ended sometime in late 1960. Thus, according to Agency records CIA was not involved in the support of this research program until after Mrs. Orlikow had ended her first stay at the Allan Memorial Institute and CIA had terminated its support before she reentered the institute. Consequently, it appears at this time that Mrs. Orlikow was not involved as a subject of MKULTRA drug testing sponsored by this Agency and CIA was not responsible for the treatment provided to her. Spprovri for Release Date tIA s I am enclosing copies of the records available to the Agency pertaining to its support of research at McGill. The University had no objection to the acknowledgment by CIA of its involvement in this activity. I trust it will alleviate Mrs. Orlikow's concerns to learn that she was not subjected to this treatment as a result of support furnished by this Agency. Very truly yoursj - � .Assi� GeneLd.J..sel Ends - 2